(Neo)adjuvant Strategies of Advanced Gastric Carcinoma: Time for a Change?

Publisher： Karger

E-ISSN： 1421-9875|22|4|345-350

ISSN： 0257-2753

Source： Digestive Diseases, Vol.22, Iss.4, 2005-03, pp. : 345-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Gastric Neuroendocrine Carcinoma with an Adenocarcinoma Component

By  

Case Reports in Gastroenterology, Vol. 6, Iss. 1, 2012-01 ,pp. : 52-57

Karger

Access to resources Recommend Favorite

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

By Kosugi Shin-Ichi   Kanda Tatsuo   Nakagawa Satoru   Ohashi Manabu   Nishimaki Tadashi   Hatakeyama Katsuyoshi  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 886-892

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer: A Review

By Harris J.   Bruckner H.  

International Journal of Pancreatology, Vol. 29, Iss. 1, 2001-03 ,pp. : 1-7

Humana Press, Inc

Access to resources Recommend Favorite

Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward

By  

Gastrointestinal Tumors, Vol. 1, Iss. 2, 2014-05 ,pp. : 99-104

Karger

Access to resources Recommend Favorite

Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition

By  

Liver Cancer, Vol. 1, Iss. 3-4, 2012-11 ,pp. : 247-256

Karger

Access to resources Recommend Favorite